Lrrk2 interaction with α-synuclein in diffuse Lewy body disease

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1229-1234

  Qing, Hong ^a,b   Zhang, Yanyan ^b   Deng, Yulin ^b   McGeer, E G ^a   McGeer, P L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Co immunoprecipitation; HEK cells; Lewy body; Parkinson disease; Synucleinopathies

Indexed keywords

ALPHA SYNUCLEIN; BRAIN EXTRACT; HYDROGEN PEROXIDE; LEUCINE RICH REPEAT KINASE 2;

ARTICLE; AUTOPSY; BRAIN; CELL ASSAY; CELL STRAIN HEK293; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; OXIDATIVE STRESS; PLASMID; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ALPHA-SYNUCLEIN; BRAIN; CELL LINE; HUMANS; IMMUNOPRECIPITATION; LEWY BODY DISEASE; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER;

EID: 70450246992     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.126     Document Type: Article

References (19)

1. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolekand Z.K., and Gasser T. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
2. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., and Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
3. Di Fonzo A., Rohe C.F., Ferreira R.J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., Sampaio C., Meco G., Barbosa E., Oostra B.A., and Bonifati V. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 (2005) 412-415
4. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., Michaels V.E., Reed T., Rudolph A., Shults C.W., Singleton A., and Foroud T. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 (2005) 410-412
5. Gasser T. Molecular genetic findings in LRRK2 American, Canadian and German Families. J. Neural Transm. Suppl. 70 (2006) 231-234
6. Higash S., Biskup S., West A.B., Trinkaus D., Dawson V.L., Faull R.L.M., Waldvogel H.J., Arai H., Dawson T.M., Moore D.J., and Emson P.C. Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res. 1155 (2007) 208-219
7. Rajput A., Dickson D.W., Robinson C.A., Ross O.A., Dachsel J.C., Lincoln S.J., Cobb S.A., Rajput M.L., and Farrer M.J. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67 8 (2006) 1506-1508
8. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., and Destee A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 (2004) 1167-1169
9. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
10. McGeer P.L., and McGeer E.G. The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Exp. Neurol. 212 (2008) 235-238
11. Perry G., Zhu X.W., Babar A.K., Siedlak S.L., Yang Q.W., Ito G., Iwatsubo T., Smith M.A., and Chen S.G. Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies. Neurodegener. Dis. 5 3-4 (2008) 222-224
12. Miklossy J., Arai T., Guo J.P., Klegeris A., Yu S., McGeer E.G., and McGeer P.L. LRRK2 expression in normal and pathologic human brain and in human cell lines. J. Neuropathol. Exp. Neurol. 65 10 (2006) 953-963
13. Qing H., Wong W., McGeer E.G., and McGeer P.L. Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem. Biophys. Res. Commun. 387 (2009) 149-152
14. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., and Iwatsubo T. Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4 (2002) 160-164
15. Zabetian C.P., Samii A., Mosley A.D., Roberts J.W., Leis B.C., Yearout D., Raskind W.H., and Griffith A. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65 (2005) 741-744
16. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., Shaw K., Bhatia K.P., Bonifati V., Quinn N.P., Lynch J., Healy D.G., Holton J.L., Revesz T., and Wood N.W. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
17. Iiou A.K.F., Leak R.K., Li L.H., and Zigmond M.J. Wild-type LRRk2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol. Dis. 32 (2008) 116-124
18. 2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants. Neurosci. Lett. 342 1-2 (2003) 124-128
19. Hashimoto H., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., and Masliah E. Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277 (2002) 11465-11472